Literature DB >> 28982671

Cohort Study of ECG Left Ventricular Hypertrophy Trajectories: Ethnic Disparities, Associations With Cardiovascular Outcomes, and Clinical Utility.

Carlos Iribarren1, Alfred D Round2, Meng Lu2, Peter M Okin3, Edward J McNulty4.   

Abstract

BACKGROUND: ECG left ventricular hypertrophy (LVH) is a well-known predictor of cardiovascular disease. However, no prior study has characterized patterns of presence/absence of ECG LVH ("ECG LVH trajectories") across the adult lifespan in both sexes and across ethnicities. We examined: (1) correlates of ECG LVH trajectories; (2) the association of ECG LVH trajectories with incident coronary heart disease, transient ischemic attack, ischemic stroke, hemorrhagic stroke, and heart failure; and (3) reclassification of cardiovascular disease risk using ECG LVH trajectories. METHODS AND
RESULTS: We performed a cohort study among 75 412 men and 107 954 women in the Northern California Kaiser Permanente Medical Care Program who had available longitudinal exposures of ECG LVH and covariates, followed for a median of 4.8 (range <1-9.3) years. ECG LVH was measured by Cornell voltage-duration product. Adverse trajectories of ECG LVH (persistent, new development, or variable pattern) were more common among blacks and Native American men and were independently related to incident cardiovascular disease with hazard ratios ranging from 1.2 for ECG LVH variable pattern and transient ischemic attack in women to 2.8 for persistent ECG LVH and heart failure in men. ECG LVH trajectories reclassified 4% and 7% of men and women with intermediate coronary heart disease risk, respectively.
CONCLUSIONS: ECG LVH trajectories were significant indicators of coronary heart disease, stroke, and heart failure risk, independently of level and change in cardiovascular disease risk factors, and may have clinical utility.
© 2017 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley.

Entities:  

Keywords:  Cornell voltage product; cohort study; electrocardiography; left ventricular hypertrophy

Mesh:

Year:  2017        PMID: 28982671      PMCID: PMC5721817          DOI: 10.1161/JAHA.116.004954

Source DB:  PubMed          Journal:  J Am Heart Assoc        ISSN: 2047-9980            Impact factor:   5.501


  43 in total

1.  2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Authors:  David C Goff; Donald M Lloyd-Jones; Glen Bennett; Sean Coady; Ralph B D'Agostino; Raymond Gibbons; Philip Greenland; Daniel T Lackland; Daniel Levy; Christopher J O'Donnell; Jennifer G Robinson; J Sanford Schwartz; Susan T Shero; Sidney C Smith; Paul Sorlie; Neil J Stone; Peter W F Wilson; Harmon S Jordan; Lev Nevo; Janusz Wnek; Jeffrey L Anderson; Jonathan L Halperin; Nancy M Albert; Biykem Bozkurt; Ralph G Brindis; Lesley H Curtis; David DeMets; Judith S Hochman; Richard J Kovacs; E Magnus Ohman; Susan J Pressler; Frank W Sellke; Win-Kuang Shen; Sidney C Smith; Gordon F Tomaselli
Journal:  Circulation       Date:  2013-11-12       Impact factor: 29.690

2.  Prognostic value of electrocardiographic criteria for left ventricular hypertrophy.

Authors:  Bill P Hsieh; Michael X Pham; Victor F Froelicher
Journal:  Am Heart J       Date:  2005-07       Impact factor: 4.749

3.  Left ventricular hypertrophy by electrocardiogram. Prevalence, incidence, and mortality in the Framingham study.

Authors:  W B Kannel; T Gordon; D Offutt
Journal:  Ann Intern Med       Date:  1969-07       Impact factor: 25.391

4.  Glycemic control and heart failure among adult patients with diabetes.

Authors:  C Iribarren; A J Karter; A S Go; A Ferrara; J Y Liu; S Sidney; J V Selby
Journal:  Circulation       Date:  2001-06-05       Impact factor: 29.690

5.  Ethnic differences in the identification of left ventricular hypertrophy in the hypertensive patient.

Authors:  J N Chapman; J Mayet; C L Chang; R A Foale; S A Thom; N R Poulter
Journal:  Am J Hypertens       Date:  1999-05       Impact factor: 2.689

6.  Cohort study of exposure to environmental tobacco smoke and risk of first ischemic stroke and transient ischemic attack.

Authors:  Carlos Iribarren; Jeanne Darbinian; Arthur L Klatsky; Gary D Friedman
Journal:  Neuroepidemiology       Date:  2004 Jan-Apr       Impact factor: 3.282

Review 7.  Accuracy of electrocardiography in diagnosis of left ventricular hypertrophy in arterial hypertension: systematic review.

Authors:  Daniel Pewsner; Peter Jüni; Matthias Egger; Markus Battaglia; Johan Sundström; Lucas M Bachmann
Journal:  BMJ       Date:  2007-08-28

8.  Improved blood pressure control associated with a large-scale hypertension program.

Authors:  Marc G Jaffe; Grace A Lee; Joseph D Young; Stephen Sidney; Alan S Go
Journal:  JAMA       Date:  2013-08-21       Impact factor: 56.272

9.  Left ventricular hypertrophy is associated with asymptomatic cerebral damage in hypertensive patients.

Authors:  Giulio Selvetella; Antonella Notte; Angelo Maffei; Valentina Calistri; Virginia Scamardella; Giacomo Frati; Bruno Trimarco; Claudio Colonnese; Giuseppe Lembo
Journal:  Stroke       Date:  2003-06-12       Impact factor: 7.914

10.  Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events.

Authors:  Peter M Okin; Richard B Devereux; Sverker Jern; Sverre E Kjeldsen; Stevo Julius; Markku S Nieminen; Steven Snapinn; Katherine E Harris; Peter Aurup; Jonathan M Edelman; Hans Wedel; Lars H Lindholm; Björn Dahlöf
Journal:  JAMA       Date:  2004-11-17       Impact factor: 56.272

View more
  7 in total

1.  A Population-wide study of electrocardiographic (ECG) norms and the effect of demographic and anthropometric factors on selected ECG characteristics in young, Southeast Asian males-results from the Singapore Armed Forces ECG (SAFE) study.

Authors:  Ching-Hui Sia; Mayank Dalakoti; Benjamin Y Q Tan; Edward C Y Lee; Xiayan Shen; Kangjie Wang; Joshua S Lee; Shalini Arulanandam; Weien Chow; Tee Joo Yeo; Khung Keong Yeo; Terrance S J Chua; Ru San Tan; Carolyn S P Lam; Daniel T T Chong
Journal:  Ann Noninvasive Electrocardiol       Date:  2019-02-01       Impact factor: 1.468

2.  Black-white Differences in Left Ventricular Hypertrophy Rates Among Young Adults with Ischemic Stroke.

Authors:  Yan Hou; Kathleen A Ryan; Carolyn A Cronin; Elizabeth M Aradine; John W Cole; Seemant Chaturvedi; Marcella A Wozniak; Prachi Mehndiratta; Michael S Phipps; Karen L Yarbrough; Mohammad Yousaf; Steven J Kittner
Journal:  J Stroke Cerebrovasc Dis       Date:  2022-07-04       Impact factor: 2.677

3.  Particulate Matter and Cardiovascular Risk in Adults with Chronic Obstructive Pulmonary Disease.

Authors:  Stacey E Alexeeff; Kamala Deosaransingh; Noelle S Liao; Stephen K Van Den Eeden; Joel Schwartz; Stephen Sidney
Journal:  Am J Respir Crit Care Med       Date:  2021-07-15       Impact factor: 30.528

4.  Modelling of longitudinal data to predict cardiovascular disease risk: a methodological review.

Authors:  David Stevens; Deirdre A Lane; Stephanie L Harrison; Gregory Y H Lip; Ruwanthi Kolamunnage-Dona
Journal:  BMC Med Res Methodol       Date:  2021-12-18       Impact factor: 4.615

5.  De novo electrocardiographic abnormalities in persons living with HIV.

Authors:  Andreas D Knudsen; Claus Graff; Jonas Bille Nielsen; Magda Teresa Thomsen; Julie Høgh; Thomas Benfield; Jan Gerstoft; Lars Køber; Klaus F Kofoed; Susanne D Nielsen
Journal:  Sci Rep       Date:  2021-10-21       Impact factor: 4.379

6.  Performance of the Electrocardiogram in the Diagnosis of Left Ventricular Hypertrophy in Older and Very Older Hypertensive Patients.

Authors:  Fernando Focaccia Povoa; Braulio Luna Filho; Henrique Tria Bianco; Celso Amodeo; Rui Povoa; Maria Teresa Nogueira Bombig; Roberto Dischinger Miranda; Simone Matheus Fischer; Maria Cristina Oliveira Izar; Francisco A H Fonseca
Journal:  Arq Bras Cardiol       Date:  2021-11       Impact factor: 2.000

7.  Prognostic significance of body mass index-adjusted criteria for left ventricular hypertrophy.

Authors:  Hesham Afify; Ho Lim Lee; Elsayed Z Soliman; Matthew J Singleton
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-08-06       Impact factor: 3.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.